Bioceltix S.A. (WSE: BCX)
Poland
· Delayed Price · Currency is PLN 82.40
-0.50 (-0.60%)
Jan 20, 2025, 12:49 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 412.18 million as of January 21, 2025. Its market cap has increased by 10.90% in one year.
Market Cap
412.18M
Enterprise Value
374.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
82.40
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 412.18M, an increase of 258.30%. That is a compound annual growth rate of 48.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 399.87M | -7.31% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.74B |
| Synektik Spólka Akcyjna | 1.91B |
| Voxel | 1.44B |
| Celon Pharma | 1.36B |
| Selvita | 855.37M |
| Ryvu Therapeutics | 694.76M |
| Centrum Medyczne ENEL-MED | 593.89M |
| Mercator Medical | 509.04M |